Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this 52-week open label study is to determine the long-term safety of a new
opioid molecule, NKTR-181, in patients with moderate to severe chronic low back pain or
chronic non-cancer pain.